Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema

Purpose: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections. Methods: This retrospective comparative study compared a group of 19 eyes with DME treated with micropu...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2018-01, Vol.28 (1), p.68-73
Main Authors: Moisseiev, Elad, Abbassi, Sam, Thinda, Sumeer, Yoon, Joseph, Yiu, Glenn, Morse, Lawrence S.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833
cites cdi_FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833
container_end_page 73
container_issue 1
container_start_page 68
container_title European journal of ophthalmology
container_volume 28
creator Moisseiev, Elad
Abbassi, Sam
Thinda, Sumeer
Yoon, Joseph
Yiu, Glenn
Morse, Lawrence S.
description Purpose: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections. Methods: This retrospective comparative study compared a group of 19 eyes with DME treated with micropulse laser to a matched control group of 19 eyes with DME treated with ranibizumab injections without micropulse laser. Recorded parameters included previous medical and ocular history, previous and subsequent ranibizumab injections administered for DME, visual acuity (VA), central macular thickness throughout the follow-up period, and the occurrence of any complications. Results: The improvement in VA was comparable in both groups, at 12 months and at the final follow-up. Patients treated with micropulse laser required significantly fewer ranibizumab injections than their controls, both at 12 months (1.7 ± 2.3 vs 5.6 ± 2.1) and by the end of the follow-up (2.6 ± 3.3 vs 9.3 ± 5.1) (p
doi_str_mv 10.5301/ejo.5001000
format article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5301_ejo_5001000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.5301_ejo.5001000</sage_id><sourcerecordid>10.5301_ejo.5001000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833</originalsourceid><addsrcrecordid>eNptkE1LAzEQhoMoWKsn_0COgmydJPvVo5S2CgUPflyX2WTWzbIfJcki_nsj9uhphuHhZd6HsVsBq0yBeKBuWmUAAgDO2EIUMk1yEPl53IWEJC-kuGRX3ncAEtapXLD2da5D68i3U2_4YLWbjnPviffoyXFHZtbkOY7BJh_b_Y7bsSMd7DTyenaGxnjgRwyWxuD5lw0tNxZrClbzAfXco-NkaMBrdtFgDL45zSV7323fNk_J4WX_vHk8JFpJGRKZNuUaC2wKXWNBNem6wDxr6tKAUgZAF2at0iYlnUsoSaaZBpFhirGOKJVasvu_3NjEe0dNdXR2QPddCah-JVVRUnWSFOm7P9rjJ1XdNLsxPvcv-gMka2jt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema</title><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)</source><creator>Moisseiev, Elad ; Abbassi, Sam ; Thinda, Sumeer ; Yoon, Joseph ; Yiu, Glenn ; Morse, Lawrence S.</creator><creatorcontrib>Moisseiev, Elad ; Abbassi, Sam ; Thinda, Sumeer ; Yoon, Joseph ; Yiu, Glenn ; Morse, Lawrence S.</creatorcontrib><description>Purpose: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections. Methods: This retrospective comparative study compared a group of 19 eyes with DME treated with micropulse laser to a matched control group of 19 eyes with DME treated with ranibizumab injections without micropulse laser. Recorded parameters included previous medical and ocular history, previous and subsequent ranibizumab injections administered for DME, visual acuity (VA), central macular thickness throughout the follow-up period, and the occurrence of any complications. Results: The improvement in VA was comparable in both groups, at 12 months and at the final follow-up. Patients treated with micropulse laser required significantly fewer ranibizumab injections than their controls, both at 12 months (1.7 ± 2.3 vs 5.6 ± 2.1) and by the end of the follow-up (2.6 ± 3.3 vs 9.3 ± 5.1) (p&lt;0.001 for both). No complications related to the micropulse laser were encountered. Conclusions: Micropulse laser is a safe and effective treatment for DME, which may achieve comparable improvement in VA along with a significant reduction in the burden of anti-VEGF injections. We suggest a treatment approach for its inclusion in the early stages of DME.</description><identifier>ISSN: 1120-6721</identifier><identifier>EISSN: 1724-6016</identifier><identifier>DOI: 10.5301/ejo.5001000</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>European journal of ophthalmology, 2018-01, Vol.28 (1), p.68-73</ispartof><rights>The Author(s) 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833</citedby><cites>FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids></links><search><creatorcontrib>Moisseiev, Elad</creatorcontrib><creatorcontrib>Abbassi, Sam</creatorcontrib><creatorcontrib>Thinda, Sumeer</creatorcontrib><creatorcontrib>Yoon, Joseph</creatorcontrib><creatorcontrib>Yiu, Glenn</creatorcontrib><creatorcontrib>Morse, Lawrence S.</creatorcontrib><title>Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema</title><title>European journal of ophthalmology</title><description>Purpose: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections. Methods: This retrospective comparative study compared a group of 19 eyes with DME treated with micropulse laser to a matched control group of 19 eyes with DME treated with ranibizumab injections without micropulse laser. Recorded parameters included previous medical and ocular history, previous and subsequent ranibizumab injections administered for DME, visual acuity (VA), central macular thickness throughout the follow-up period, and the occurrence of any complications. Results: The improvement in VA was comparable in both groups, at 12 months and at the final follow-up. Patients treated with micropulse laser required significantly fewer ranibizumab injections than their controls, both at 12 months (1.7 ± 2.3 vs 5.6 ± 2.1) and by the end of the follow-up (2.6 ± 3.3 vs 9.3 ± 5.1) (p&lt;0.001 for both). No complications related to the micropulse laser were encountered. Conclusions: Micropulse laser is a safe and effective treatment for DME, which may achieve comparable improvement in VA along with a significant reduction in the burden of anti-VEGF injections. We suggest a treatment approach for its inclusion in the early stages of DME.</description><issn>1120-6721</issn><issn>1724-6016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptkE1LAzEQhoMoWKsn_0COgmydJPvVo5S2CgUPflyX2WTWzbIfJcki_nsj9uhphuHhZd6HsVsBq0yBeKBuWmUAAgDO2EIUMk1yEPl53IWEJC-kuGRX3ncAEtapXLD2da5D68i3U2_4YLWbjnPviffoyXFHZtbkOY7BJh_b_Y7bsSMd7DTyenaGxnjgRwyWxuD5lw0tNxZrClbzAfXco-NkaMBrdtFgDL45zSV7323fNk_J4WX_vHk8JFpJGRKZNuUaC2wKXWNBNem6wDxr6tKAUgZAF2at0iYlnUsoSaaZBpFhirGOKJVasvu_3NjEe0dNdXR2QPddCah-JVVRUnWSFOm7P9rjJ1XdNLsxPvcv-gMka2jt</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Moisseiev, Elad</creator><creator>Abbassi, Sam</creator><creator>Thinda, Sumeer</creator><creator>Yoon, Joseph</creator><creator>Yiu, Glenn</creator><creator>Morse, Lawrence S.</creator><general>SAGE Publications</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180101</creationdate><title>Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema</title><author>Moisseiev, Elad ; Abbassi, Sam ; Thinda, Sumeer ; Yoon, Joseph ; Yiu, Glenn ; Morse, Lawrence S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moisseiev, Elad</creatorcontrib><creatorcontrib>Abbassi, Sam</creatorcontrib><creatorcontrib>Thinda, Sumeer</creatorcontrib><creatorcontrib>Yoon, Joseph</creatorcontrib><creatorcontrib>Yiu, Glenn</creatorcontrib><creatorcontrib>Morse, Lawrence S.</creatorcontrib><collection>CrossRef</collection><jtitle>European journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moisseiev, Elad</au><au>Abbassi, Sam</au><au>Thinda, Sumeer</au><au>Yoon, Joseph</au><au>Yiu, Glenn</au><au>Morse, Lawrence S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema</atitle><jtitle>European journal of ophthalmology</jtitle><date>2018-01-01</date><risdate>2018</risdate><volume>28</volume><issue>1</issue><spage>68</spage><epage>73</epage><pages>68-73</pages><issn>1120-6721</issn><eissn>1724-6016</eissn><abstract>Purpose: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections. Methods: This retrospective comparative study compared a group of 19 eyes with DME treated with micropulse laser to a matched control group of 19 eyes with DME treated with ranibizumab injections without micropulse laser. Recorded parameters included previous medical and ocular history, previous and subsequent ranibizumab injections administered for DME, visual acuity (VA), central macular thickness throughout the follow-up period, and the occurrence of any complications. Results: The improvement in VA was comparable in both groups, at 12 months and at the final follow-up. Patients treated with micropulse laser required significantly fewer ranibizumab injections than their controls, both at 12 months (1.7 ± 2.3 vs 5.6 ± 2.1) and by the end of the follow-up (2.6 ± 3.3 vs 9.3 ± 5.1) (p&lt;0.001 for both). No complications related to the micropulse laser were encountered. Conclusions: Micropulse laser is a safe and effective treatment for DME, which may achieve comparable improvement in VA along with a significant reduction in the burden of anti-VEGF injections. We suggest a treatment approach for its inclusion in the early stages of DME.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.5301/ejo.5001000</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1120-6721
ispartof European journal of ophthalmology, 2018-01, Vol.28 (1), p.68-73
issn 1120-6721
1724-6016
language eng
recordid cdi_crossref_primary_10_5301_ejo_5001000
source SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024:2025 extension (reading list)
title Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-05T07%3A52%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subthreshold%20micropulse%20laser%20reduces%20anti-VEGF%20injection%20burden%20in%20patients%20with%20diabetic%20macular%20edema&rft.jtitle=European%20journal%20of%20ophthalmology&rft.au=Moisseiev,%20Elad&rft.date=2018-01-01&rft.volume=28&rft.issue=1&rft.spage=68&rft.epage=73&rft.pages=68-73&rft.issn=1120-6721&rft.eissn=1724-6016&rft_id=info:doi/10.5301/ejo.5001000&rft_dat=%3Csage_cross%3E10.5301_ejo.5001000%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c322t-24f89a7af7cba7ebecb7a65fb8d033d00c7d934f4ec6208e245c015a4a9421833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_sage_id=10.5301_ejo.5001000&rfr_iscdi=true